Aurinia Pharmaceuticals (AUPH) News Today → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free AUPH Stock Alerts $5.16 +0.06 (+1.18%) (As of 05/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conferencebusinesswire.com - May 7 at 6:00 AMAurinia Pharmaceuticals (NASDAQ:AUPH) Upgraded at StockNews.comamericanbankingnews.com - May 6 at 5:44 AMResearch Analysts Offer Predictions for Aurinia Pharmaceuticals Inc.'s Q4 2024 Earnings (NASDAQ:AUPH)americanbankingnews.com - May 6 at 3:34 AMAurinia Pharmaceuticals (NASDAQ:AUPH) Stock Rating Upgraded by StockNews.commarketbeat.com - May 3 at 11:59 PMAurinia Pharmaceuticals Inc. (AUPH) Q1 2024 Earnings Call Transcriptseekingalpha.com - May 2 at 3:00 PMAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Gap Up to $5.20marketbeat.com - May 2 at 12:45 PMLeerink Partners Keeps Their Buy Rating on Aurinia Pharmaceuticals (AUPH)markets.businessinsider.com - May 2 at 8:08 AMAurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Resultsbusinesswire.com - May 2 at 6:00 AMAurinia Pharmaceuticals is about to announce earnings — here's what Wall Street expectsmarkets.businessinsider.com - May 1 at 5:07 PMAurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Monthbusinesswire.com - May 1 at 6:00 AMAurinia: Updated Lupkynis Label Should Keep Sales Growth Momentum Goingseekingalpha.com - April 30 at 4:04 PMThe U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Programbusinesswire.com - April 30 at 6:00 AMAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 6.9% in Aprilmarketbeat.com - April 29 at 12:05 PMAurinia Pharmaceuticals: Potential For Significant Upside By Year-End 2024seekingalpha.com - April 18 at 2:30 PMAurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 52-Week Low at $4.82marketbeat.com - April 18 at 10:58 AMUPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conferencebusinesswire.com - April 16 at 10:48 AMAurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024businesswire.com - April 15 at 6:00 AMShort Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Increases By 14.9%marketbeat.com - April 14 at 1:27 PMAurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conferencebusinesswire.com - April 9 at 6:00 AMBRIEF-Soilbuild Construction Says Group Awarded New Contractssg.finance.yahoo.com - April 9 at 1:40 AMWhen Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?finance.yahoo.com - April 7 at 1:56 PMAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Up 4.6%marketbeat.com - April 1 at 5:30 PMAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Short Interest Down 12.0% in Marchmarketbeat.com - March 31 at 8:14 AMAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month Low at $4.94marketbeat.com - March 26 at 5:47 PMAurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 12-Month Low at $4.96marketbeat.com - March 19 at 11:51 AM11 Oversold Biotech Stocks To Buy Right Nowfinance.yahoo.com - March 17 at 6:30 PMAUPH Mar 2024 3.000 callfinance.yahoo.com - March 14 at 10:16 PMAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Sees Large Decrease in Short Interestmarketbeat.com - March 14 at 8:22 AMAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 1-Year Low at $5.34marketbeat.com - March 11 at 5:28 PMTrexquant Investment LP Has $423,000 Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)marketbeat.com - March 11 at 5:14 AMWe're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burnfinance.yahoo.com - March 8 at 5:31 PMAurinia Pharma: Cheaper Now, But Buyout Hopes Dashedseekingalpha.com - March 5 at 3:27 PMShort Interest in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Drops By 9.1%marketbeat.com - March 3 at 10:46 AMAurinia Pharmaceuticals: Strong Buy Rating Amidst Share Repurchase and Promising LUPKYNIS Prospectsmarkets.businessinsider.com - March 1 at 9:09 PMHC Wainwright Reiterates Buy Rating for Aurinia Pharmaceuticals (NASDAQ:AUPH)marketbeat.com - March 1 at 2:51 PMCantor Fitzgerald Comments on Aurinia Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:AUPH)marketbeat.com - February 29 at 8:53 AMAurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Programfinance.yahoo.com - February 29 at 8:52 AMAurinia Pharmaceuticals Inc (AUPH)investing.com - February 28 at 1:32 AMAurinia to Participate in Upcoming Investor Healthcare Conferencesbusinesswire.com - February 27 at 8:30 AMAUPH Oct 2024 8.000 callfinance.yahoo.com - February 26 at 8:46 AMAUPH Jan 2025 15.000 callfinance.yahoo.com - February 23 at 12:39 PMAUPH Oct 2024 6.000 putfinance.yahoo.com - February 23 at 12:39 PMAurinia Pharmaceuticals (NASDAQ:AUPH) PT Lowered to $10.00marketbeat.com - February 23 at 12:21 PMHC Wainwright Trims Aurinia Pharmaceuticals (NASDAQ:AUPH) Target Price to $13.00marketbeat.com - February 22 at 8:26 AMAurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year Low at $5.42marketbeat.com - February 21 at 10:47 AMAurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectationsfinance.yahoo.com - February 17 at 10:41 AMAurinia Pharmaceuticals (NASDAQ:AUPH) Price Target Cut to $9.00marketbeat.com - February 16 at 2:40 PMAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 16 at 1:11 PMNew Corporate Activity and Growth Risk for Aurinia Pharmaceuticals – What’s the Latest?msn.com - February 16 at 8:10 AMAurinia Pharmaceuticals 2023 Earnings Review: Calling 'Time' In Last Chance Saloonseekingalpha.com - February 15 at 3:00 PM Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar... Get your free information kit NOW, before it's too late. AUPH Media Mentions By Week AUPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUPH News Sentiment▼0.550.40▲Average Medical News Sentiment AUPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUPH Articles This Week▼142▲AUPH Articles Average Week Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OCUL News PRAX News PRTC News PLRX News LBPH News BCYC News ARCT News ZNTL News EOLS News PAHC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUPH) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
